Clinical Trial

PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Study acronym: PaCaReg
Recruiting
View on ClinicalTrials.gov →
Summary
PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-09-18.
Trial Details
NCT Number NCT04099134
Lead Sponsor University of Ulm
Conditions Pancreas Adenocarcinoma, Pancreas Cancer
Enrollment 5,000 participants
Start Date 2018-10-10
Primary Completion 2028-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2019-09-25